(Q40437300)

20 September 2017

A clinically relevant SCID-hu in vivo model of human multiple myeloma (English)

1 reference

20 September 2017

12

Kenneth C Anderson

1 reference

20 September 2017

Pierfrancesco Tassone

1

object named as

Pierfrancesco Tassone

1 reference

20 September 2017

Paola Neri

2

1 reference

20 September 2017

Daniel R Carrasco

3

1 reference

20 September 2017

Renate Burger

4

1 reference

20 September 2017

Victor S Goldmacher

5

1 reference

20 September 2017

Robert Fram

6

1 reference

20 September 2017

Vidit Munshi

7

1 reference

20 September 2017

Masood A Shammas

8

1 reference

20 September 2017

Laurence Catley

9

1 reference

20 September 2017

Gary S Jacob

10

1 reference

20 September 2017

Salvatore Venuta

11

1 reference

20 September 2017

Nikhil C Munshi

13

1 reference

20 September 2017

language of work or name

English

0 references

publication date

7 April 2005

1 reference

20 September 2017

1 reference

20 September 2017

106

1 reference

20 September 2017

713-716

1 reference

20 September 2017

2

1 reference

Azaspirane (N-N-diethyl-8,8-dipropyl-2-azaspiro [4.5] decane-2-propanamine) inhibits human multiple myeloma cell growth in the bone marrow milieu in vitro and in vivo

20 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895174

Recent advances in the management of multiple myeloma

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895174

Establishment of a new model of human multiple myeloma using NOD/SCID/gammac(null) (NOG) mice

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895174

Moving disease biology from the lab to the clinic

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895174

Molecular mechanisms of novel therapeutic approaches for multiple myeloma

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895174

Targeted therapy for multiple myeloma

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895174

Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895174

Gp130 and ras mediated signaling in human plasma cell line INA-6: a cytokine-regulated tumor model for plasmacytoma

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895174

New xenograft model of multiple myeloma and efficacy of a humanized antibody against human interleukin-6 receptor.

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895174

Development of an in vivo model of human multiple myeloma bone disease

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895174

Disseminated growth of a human multiple myeloma cell line in mice with severe combined immunodeficiency disease.

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895174

The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895174

Cytotoxic activity of the maytansinoid immunoconjugate B-B4-DM1 against CD138+ multiple myeloma cells

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895174

The IL-6 receptor antagonist SANT-7 overcomes bone marrow stromal cell-mediated drug resistance of multiple myeloma cells

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895174

Human hematopoiesis in SCID mice implanted with human adult cancellous bone.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895174

Modeling human lymphoid precursor cell gene therapy in the SCID-hu mouse.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895174

Implantation and maintenance of functional human bone marrow in SCID-hu mice

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895174

Preclinical analysis of cytokine therapy in the SCID-hu mouse

20 August 2018

1 reference

12 December 2020

Growth of human myeloid leukemias in the human marrow environment of SCID-hu mice

1 reference

12 December 2020

Engraftment of human hematopoietic precursor cells with secondary transfer potential in SCID-hu mice

1 reference

12 December 2020

The development of a model for the homing of multiple myeloma cells to human bone marrow

1 reference

12 December 2020

Primary myeloma cells growing in SCID-hu mice: a model for studying the biology and treatment of myeloma and its manifestations

1 reference

12 December 2020

10.1182/BLOOD-2005-01-0373

Identifiers

DOI

1 reference

20 September 2017

1 reference

20 September 2017

1 reference